曲美他嗪用于老年冠心病心力衰竭患者对其心功能、心肌重塑的影响
摘要
关键词
全文:
PDF参考
[1]BIRNA,BJARNASON-WEHRENS, BERNHARD,SCHWAAB, NILS,REISS, et al. Resistance Training in Patients With Coronary Artery Disease, Heart Failure, and Valvular Heart Disease: A REVIEW WITH SPECIAL EMPHASIS ON OLD AGE, FRAILTY, AND PHYSICAL LIMITATIONS[J]. Journal of cardiopulmonary rehabilitation and prevention,2022,42(5):304-315. [2]ALATAS, OMER DOGAN, BITEKER, MURAT, DEMIR, AHMET, et al. Comparison of objective nutritional indexes for the prediction of in-hospital mortality among elderly patients with acute heart failure[J]. European journal of emergency medicine: Official journal of the European Society for Emergency Medicine,2020,27(5):362-367. [3]靳立娟,王小荣,崔荣恩. 美托洛尔联合曲美他嗪治疗冠心病合并慢性心力衰竭的临床疗效及其对生存质量的影响[J]. 临床合理用药杂志,2021,14(6):83-85. [4]MIQUEL GUAL, ALBERT ARIZA-SOLÉ, FRANCESC FORMIGA, et al. Diabetes mellitus is not independently associated with mortality in elderly patients with ST-segment elevation myocardial infarction. Insights from the Codi Infart registry[J]. Coronary artery disease,2020,31(1):1-6.[5]NGOC-THANH-VAN NGUYEN, DIEP TUAN TRAN, PHAM LE AN, et al. Clinical Phenotypes and Age-Related Differences in Presentation, Treatment, and Outcome of Heart Failure with Preserved Ejection Fraction: A Vietnamese Multicenter Research[J]. 2021,2021(Pt.1):4587678.[6]刘长仁,田宝祎,郭庆焕. 美托洛尔与曲美他嗪治疗老年冠心病心力衰竭的疗效及对患者心功能、心肌重塑和炎症因子的影响[J]. 中西医结合心血管病电子杂志,2020,8(15):54.[7]王会春,李霞,李黎,等. 曲美他嗪联合美托洛尔对冠状动脉粥样硬化性心脏病心力衰竭患者血浆脑钠肽水平及心功能的影响[J]. 实用医技杂志,2020,27(5):635-636. [8]张春洋. 美托洛尔与曲美他嗪联合治疗老年冠心病心力衰竭的临床疗效及对患者心功能,心肌重塑和炎症因子的影响[J]. 航空航天医学杂志,2022,33(6):645-647. [9]王月峰,张其相,岳永焕. 美托洛尔与曲美他嗪治疗老年冠心病心力衰竭的疗效及对患者心功能、心肌重塑和炎症因子的影响[J]. 临床研究,2021,29(5):81-83.[10]刘艳霞,文静. 美托洛尔与曲美他嗪治疗老年冠心病心力衰竭的疗效及对患者心功能、心肌重塑和炎症因子的影响[J]. 心血管病防治知识,2020,10(9):18-20.
DOI: http://dx.doi.org/10.12361/2661-3603-05-17-144222
Refbacks
- 当前没有refback。